Download PDF: https://bit.ly/2LdHVej

The non-invasive prenatal testing market is witnessing significant growth across the globe owing to factors such as high risk of chromosomal abnormalities with increasing maternal age, growing preference for non-invasive techniques over invasive methods, launch of new and advanced products, improving reimbursement scenario for NIPT, and programs focusing on increasing the awareness of NIPT. The increasing use of NIPT in detection of Trisomy (Down syndrome, Edwards’s syndrome, and Patau syndrome), Microdeletion syndrome, and other applications (Monogenic disorders, Klinefelter syndrome, gender detection, and rhesus (Rh) blood type) also play a vital role in the development of this market. Key players in the market focus on partnerships, collaborations, and agreements; product launches, expansions; and acquisitions to strengthen their positions in the global market.
The NIPT market is segmented based on product, method, application, end user, and region. On the basis of product, the market is segmented into consumables and instruments. The consumables segment offer lucrative growth opportunities and represent a new revenue pocket for the market owing to the repeated requirements of consumables in NIPT. The consumables segment is further divided into assay kits & reagents and disposables. The instruments segment is classified into ultrasound devices, NGS systems, PCR instruments, microarrays, and other instruments.

On the basis of method, the NIPT market is segmented into ultrasound detection, biochemical screening tests, fetal cells in maternal blood tests, and cell-free DNA in maternal plasma tests. In 2016, the ultrasound detection segment accounted for the largest share of the NIPT market. However, the cell-free DNA in maternal plasma tests segment is expected to grow at the highest CAGR during the forecast period. The increasing demand for cf-DNA based techniques in NIPT testing and rising government initiatives to provide prenatal services are expected to contribute to the growth of this market in the coming years.

On the basis of application, the NIPT market is segmented into Trisomy, microdeletion syndrome, and other applications. Trisomy forms the largest application segment and is slated to grow at the highest CAGR during the forecast period. This is mainly attributed to the increasing maternal age and rising incidence of chromosomal abnormalities.
On the basis of end user, the NIPT market is segmented into diagnostic laboratories and hospitals. In 2016, the diagnostic laboratories segment accounted for the largest share of the market. Growth in this end-user segment can be attributed to the high incidence of chromosomal abnormalities.
Currently, North America dominates the market, followed by Europe. However, the market in Asia is expected to witness the highest growth due to the increasing healthcare infrastructure. In addition, increasing awareness programs, rising disposable income, and increasing interest of players to expand in these emerging economies will propel the growth of the market.

To get more Information: https://www.marketsandmarkets.com/Market-Reports/non-invasive-prenatal-testing-market-145607690.html

MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : +1-888-600-6441
UK : +44-800-368-9399
[email protected]